Both a type and B type Epstein-Barr virus nuclear antigen 6 interact with RBP-2N

Journal of General Virology

Volumn 78, Issue 7, 1997, Pages 1671-1674

  Young, David B ^a   Krauer, Kenia ^a   Kienzle, Norbert ^a   Sculley, Tom ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS ANTIGEN; DNA BINDING PROTEIN; MUTANT PROTEIN; VIRUS ANTIGEN;

ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; STRUCTURE ACTIVITY RELATION; YEAST;

HUMAN HERPESVIRUS 4;

EID: 0030842029     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-78-7-1671     Document Type: Article

References (22)

1. Alfieri, C., Birkenbach, M. & Kieff, E. (1991). Early events in Epstein-Barr virus infection of human B lymphocytes. Virology 181, 595-608.
2. Amakawa, R., Jing, W., Ozawa, K., Matsunami, N., Hamaguchi, Y., Matsuda, F., Kawaichi, M. & Honjo, T. (1993). Human Jk recombination signal binding protein gene (IGKJRB): comparison with its mouse homologue. Genomics 17, 306-315.
3. κ, by direct protein-protein interaction with Drosophila Hairless. Genes & Development 8, 2491-2503.
4. Dou, S., Zeng, X., Cortes, P., Erdjument-Bromage, H., Tempst, P., Honjo, T. & Vales, L. D. (1994). The recombination signal sequence-binding protein RBP-2N functions as a transcriptional repressor. Molecular and Cellular Biology 14, 3310-3319.
5. Hammerschmidt, W. & Sugden, B. (1989). Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes. Nature 340, 393-397.
6. κ transcriptional repression domain by Epstein-Barr virus EBNA2. Science 268, 560-563.
7. Jin, X. W. & Speck, S. H. (1992). Identification of critical cis elements involved in mediating Epstein-Barr virus nuclear antigen 2-dependent activity of an enhancer located upstream of the viral BamHI C promoter. Journal of Virology 66, 2846-2852.
8. κ and PU.1. Journal of Virology 69, 253-262.
9. κ in Epstein-Barr virus-transformed B lymphocytes. Journal of Virology 70, 4179-4183.
10. κ in B-lymphocytes. Virology 226, 346-353.
11. Ling, P. D., Rawlins, D. R. & Hayward, S. D. (1993). The Epstein-Barr virus immortalizing protein EBNA-2 is targeted to DNA by a cellular enhancer-binding protein. Proceedings of the National Academy of Sciences, USA 90, 9237-9241.
12. Mannick, J. B., Cohen, J. I., Birkenbach, M., Marchini, A. & Kieff, E. (1991). The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation. Journal of Virology 65, 6826-6837.
13. Marshall, D. & Sample, C. (1995). Epstein-Barr virus nuclear antigen 3C is a transcriptional regulator. Journal of Virology 69, 3624-3630.
14. Petti, L., Sample, J., Wang, F. & Kieff, E. (1988). A fifth Epstein-Barr virus nuclear protein (EBNA3C) is expressed in latently infected growth-transformed lymphocytes. Journal of Virology 62, 1330-1338.
15. Rickinson, A. B. & Kieff, E. (1996). Epstein-Barr virus. In Fields Virology, 3rd edn, pp. 2397-2436. Edited by B. N. Fields, D. M. Knipe & P. M. Howley. Philadelphia: Lippencott-Raven Publishers.
16. Rickinson, A., Young, L. & Rowe, M. (1987). Influence of the Epstein-Barr virus nuclear antigen EBNA-2 on the growth phenotype of virus-transformed B cells. Journal of Virology 61, 1310-1317.
17. κ. Journal of Virology 69, 3108-3116.
18. κ. Journal of Virology 70, 3068-3074.
19. Roux, L. A., Kerdiles, B., Walls, D., Dedieu, J.-F. & Perricaudet, M. (1994). The Epstein-Barr virus determined nuclear antigens EBNA-3A, -3B and -3C repress EBNA-2-mediated transactivation of the viral terminal protein 1 gene promoter. Virology 205, 596-602.
20. Tomkinson, B., Robertson, E. & Kieff, E. (1993). Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation. Journal of Virology 67, 2014-2025.
21. κ. Nucleic Acids Research 22, 965-971.
22. κ. Journal of Virology 70, 4228-4236.